Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon Rally Justified, But Outstanding Issues May Limit Upside
Seeking Alpha
Monday, January 9, 2012 - 10:29am
tags:
Dendreon, Provenge
There have been red faces at AstraZeneca after the company sent confidential information to analysts by mistake
InPharm
Monday, January 9, 2012 - 10:14am
tags:
guidance, AstraZeneca
Bristol’s Buy of Inhibitex for Hepatitis Drug Won’t Be Last
Bloomberg
Monday, January 9, 2012 - 10:12am
tags:
Bristol-Myers Squibb, M&A, Inhibitex, hepatitis C
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference
Xconomy
Monday, January 9, 2012 - 10:10am
tags:
JPMorgan, IPOs, Amgen, FDA, innovation
Novartis Recalls OTC Meds Made At Troubled Plant
Pharmalot
Monday, January 9, 2012 - 10:03am
tags:
Novartis, recalls, OTC
Optimer provides update on DIFICID tablets launch
The Fly on the Wall
Monday, January 9, 2012 - 10:01am
tags:
Optimer, Dificid
Shares of hepatitis C drug developers rise on Bristol-Myers' $2.5B deal for Inhibitex
Yahoo/AP
Monday, January 9, 2012 - 9:57am
tags:
hepatitis C, Bristol-Myers Squibb, M&A, Inhibitex, Gilead, Pharmasset
BDSI Might Again Be Ready For Prime Time
Seeking Alpha
Monday, January 9, 2012 - 9:55am
tags:
BioDelivery Sciences, BEMA Buprenorphine, Endo
S&P: Bristol-Myers announcement will not affect rating
Reuters
Monday, January 9, 2012 - 9:53am
tags:
Bristol-Myers Squibb, M&A, Inhibitex
UK cost agency wants more data on Bayer anti-clot drug
Reuters
Monday, January 9, 2012 - 9:52am
tags:
UK, Bayer, Xarelto
AstraZeneca reaffirms EPS guidance for 2011
Marketwatch
Monday, January 9, 2012 - 9:51am
tags:
AstraZeneca, guidance
Theravance Shares Slide on Lung Drug Deaths
TheStreet.com
Monday, January 9, 2012 - 9:51am
tags:
Relovair, GSK, Theravance
J&J to Oppose Texas in $1 Billion Trial Over Risperdal Marketing Practices
Bloomberg
Monday, January 9, 2012 - 9:23am
tags:
off-label, JNJ, Texas, Risperdal
Biotech drug makers aim to extend brand dominance
Reuters
Monday, January 9, 2012 - 9:18am
tags:
branding, biotech
Bristol-Myers to Acquire Inhibitex for $2.5 Billion
NY Times, NY
Monday, January 9, 2012 - 9:15am
tags:
Bristol-Myers Squibb, Inhibitex, M&A
Sector Snap: Specialty drugs in 2012
BusinessWeek
Sunday, January 8, 2012 - 12:58pm
tags:
Salix, Cubist Pharmaceuticals, Ironwood Pharmaceuticals, Emergent BioSolutions, Xifaxin, Cubicin, Alkermes, Questcor Pharmaceuticals
Boston lawsuit claims DES-breast cancer link
Yahoo/AP
Sunday, January 8, 2012 - 12:55pm
tags:
DES, breast cancer
China Biotech In Review: China Unveils Biotech Development Plan 2010-2020
Seeking Alpha
Sunday, January 8, 2012 - 12:53pm
tags:
AstraZeneca, China Kanghui, Ascletis
Ampio Is A Compelling Short Sale Idea
Seeking Alpha
Sunday, January 8, 2012 - 12:51pm
tags:
Ampio Pharmaceuticals
The Magic Formula for Biotech
Motley Fool
Sunday, January 8, 2012 - 12:50pm
tags:
Gilead, Amgen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.